The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Parsons James T. since 2018.
This trader's CIK number is 1759855.
At the time of last reporting, Parsons James T. was the Chief Financial Officer of Trillium Therapeutics Inc.. (stock ticker symbol TRIL).
Also see all insider trading activities at Trillium Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | DMAC | 2,250 | $9,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | TRIL | 0 | $0 | 8,505 | $134,268 | 8,505 | $61,618 |
1. Diamedica Therapeutics Inc. (DMAC)
2. Trillium Therapeutics Inc. (TRIL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-12-11 | DMAC | Buy | 2,250 | 4.00 | 9,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-08 | TRIL | Sale | 8,505 | 15.79 | 134,268 |
| 2021-01-08 | TRIL | Option Ex | 8,505 | 7.25 | 61,618 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Parsons James T. (Chief Financial Officer of Trillium Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.